Stille

Stille Long-term Debt

The Long-Term Debt of Stille (STIL.ST) as of Oct 24, 2026 is 93.54 M SEK. In the previous year, Long-Term Debt was 35.98 M SEK — a change of 159.96% (higher).

Long-term Debt

93.54 MSEK

YoY

159.96%

Last updated:

Long-Term Debt of Stille is 2025 93.54 M SEK. Long-Term Debt of Stille was 2024 35.98 M SEK. It decreases by 159.96% higher compared to the previous year.

The Stille Long-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Long-term Debt
Date
Long-term Debt
Jan 1, 2018
248,000.00 SEK
Jan 1, 2019
23.82 M SEK
Jan 1, 2020
21.64 M SEK
Jan 1, 2021
68.27 M SEK
Jan 1, 2022
57.80 M SEK
Jan 1, 2023
38.07 M SEK
Jan 1, 2024
35.98 M SEK
Jan 1, 2025
93.54 M SEK
The Stille Long-term Debt history
YEARLong-term DebtYoY
93.54 MSEK+159.96%
35.98 MSEK-5.47%
38.07 MSEK-34.14%
57.80 MSEK-15.34%
68.27 MSEK+215.56%
21.64 MSEK-9.17%
23.82 MSEK+9,504.84%
248,000.00SEK-53.82%
537,000.00SEK+6.76%
503,000.00SEK-8.04%
547,000.00SEK-68.74%
1.75 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Stille Stock analysis

What does Stille do? Stille AB generates revenue by developing and selling medical equipment through two distinct business lines. The Surgery business area focuses on handcrafted, forged surgical instruments for open surgery, particularly in cardiovascular, reconstructive, and aesthetic plastic surgery. This segment produces essential tools such as scissors, forceps, artery forceps, needle holders, and clamps for medical professionals requiring precision instruments. The second revenue stream comes from the Patient Positioning area, which manufactures specialized procedure-specific tables. These devices are designed for cardiovascular surgery as well as gynecology, urology, and urodynamic examinations. By offering tailored positioning solutions for these specific medical fields, the company supports clinical procedures that require precise patient alignment. The company's operational structure includes wholly owned subsidiaries Stille Surgical Inc. and Stille Incentive AB, which support its manufacturing and distribution efforts. In 2013, the company adjusted its portfolio by selling its Sonesta business unit to ADDvise Lab Solutions publ AB, allowing it to focus on its core surgical and positioning equipment offerings. Stille is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Stille stock

Long-Term Debt of Stille is 93.54 M SEK in 2025.

Long-Term Debt of Stille changed from 35.98 M SEK to 93.54 M SEK, representing a 159.96% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Long-Term Debt Stille since 2006 – with annual values, charts, and detailed analysis.

Long-term debt represents obligations due after one year. It is a key component of a company's capital structure and leverage.

Long-Term Debt's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Long-Term Debt's Stille historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Stille

All Key Metrics — Stille